Skip to main content

26 January 2022

Last updated: Wednesday 26 January 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The promise of episomal reprogramming

Sunday 24 November 2013

Interviewee/Contributor

Nick Seay

Organisation

Cellular Dynamics International Inc

Pfizer commits to stem-cell therapeutics

Sunday 7 June 2009

Interviewee/Contributor

Ruth McKernan

Organisation

Pfizer Regenerative Medicine

Organisations

Oxford Capital Partners Ltd
Fieldfisher LLP
Merck Sharp & Dohme (Europe)
US National Cancer Institute
Neem Biotech Ltd
ThromboGenics NV
Harvard Stem Cell Institute
Independent healthcare analyst
Poxel SA
Symphogen A/S

Interviewees and Contributers

Gerben Moolhuizen and Kees Melief
Kevin Cox
Glenn Crocker
Kirsten Drejer
Alcide Barberis
Marc Rogers
Dawn Firmin
Bradley Bolzon
Mick Cooper
Stephen Poole

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Anders Tullgren joins BerGenBio

Thursday 13 January 2022

BiVictriX Therapeutics appoints CFO

Thursday 13 January 2022

Faron appoints new CMO

Thursday 13 January 2022

MiNA Therapeutics appoints directors

Thursday 13 January 2022

Agomab expands leadership team

Thursday 13 January 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form